Related Experiment Video
Updated: Jun 20, 2026

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
Published on: July 24, 2021
Treatment of pediatric Gram-positive multidrug-resistant infections
1Case Western Reserve University School of Medicine, Cleveland, Ohio 44106-5000, USA. Jeffrey.Blumer@UHhospitals.org
Insights
Gram-positive bacterial infections are common in children. Pharmacokinetic and pharmacodynamic data help select appropriate antimicrobial treatments for pediatric patients, addressing resistance and developmental changes.
Area of Science:
- Pediatric infectious diseases
- Pharmacology
- Microbiology
Background:
- Gram-positive organisms cause the majority of bacterial infections in pediatric populations.
- Antimicrobial therapy for children is often empirical due to evolving resistance patterns.
- Pediatric patients undergo significant physiological changes affecting antibiotic disposition.
Purpose of the Study:
- To highlight the importance of pharmacokinetic, pharmacodynamic, and pharmaceutical factors in pediatric antimicrobial selection.
- To address the challenges in treating Gram-positive infections in infants, children, and adolescents.
- To emphasize the availability of tools for appropriate antimicrobial agent selection.
Main Methods:
- Review of pharmacokinetic, pharmacodynamic, and pharmaceutical determinants of antimicrobial efficacy.
- Analysis of physiological changes in pediatric patients impacting antibiotic disposition.
- Identification of tools for selecting appropriate antimicrobial agents.
Main Results:
- Gram-positive infections constitute a significant burden in pediatric community-acquired and hospital-acquired settings.
- Empirical antimicrobial treatment in children is common despite emerging resistance.
- Pharmacological principles are crucial for effective antimicrobial therapy in pediatric patients.
Conclusions:
- Effective antimicrobial treatment for Gram-positive infections in pediatric patients requires consideration of pharmacokinetic, pharmacodynamic, and pharmaceutical data.
- Understanding developmental changes in antibiotic disposition is essential for optimizing therapy.
- Utilizing specialized data enables appropriate antimicrobial selection for Gram-positive infections in children.
Abstract:
Gram-positive organisms are the most common cause of bacterial infections in infants, children, and adolescents, accounting for 80% of community-acquired and 60% of hospital-acquired bacterial infections. Antimicrobial treatment for infants and children is largely empirical in both the outpatient and hospital settings, despite emerging resistance patterns. Effective antimicrobial treatment from a pharmacological perspective relies on pharmacokinetic, pharmacodynamic, and pharmaceutical determinants. Pediatric patients present an additional challenge in selecting appropriate antimicrobial treatment for a specific pathogen because growth from infancy to sexual maturity results in profound changes in antibiotic disposition. Utilizing carefully generated pharmacokinetic, pharmacodynamic, and pharmaceutical data, tools exist to select the appropriate antimicrobial agent for treatment of Gram-positive infections in pediatric patients.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Mechanism of Antibiotic Resistance in MRSA
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
